期刊文献+

我国川东北地区多发性肌炎/皮肌炎合并间质性肺疾病患者的临床特征及其影响因素研究 被引量:9

Clinical Characteristics and Influencing Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in the Northeast Sichuan Province in China
下载PDF
导出
摘要 背景多发性肌炎(PM)/皮肌炎(DM)患者合并间质性肺疾病(ILD)是PM/DM主要致死因素,致死率在50%以上。目前国内对PM/DM合并ILD(PM/DM-ILD)临床特征及其影响因素的研究较少,且研究结果各不相同,尚缺乏有效证据证实哪些因素与PM/DM-ILD的发生有关。目的探讨PM/DM-ILD患者的临床特征及其影响因素。方法选取2014-01-01至2018-06-30于川北医学院附属医院诊治的119例PM/DM患者为研究对象,将其分为ILD组与非间质性肺疾病(NILD)组。比较两组一般情况、临床表现、实验室指标、肺部高分辨率CT(HRCT)结果及预后情况。采用逐步Logistic回归分析PM/DM-ILD的影响因素。结果ILD组患者年龄,关节炎首发、呼吸道症状首发、技工手、雷诺现象、干咳、咳痰、活动后气促、发热、关节炎发生率,红细胞沉降率(ESR)、球蛋白(GLOB)水平,抗Jo-1抗体阳性率高于NILD组,肌无力首发、肌酸激酶(CK)、CK/天冬氨酸氨基转移酶(AST)、清蛋白(ALB)水平低于NILD组(P<0.05)。ILD组中60例患者肺部HRCT以条索影(68.3%,41/60)、斑片影(68.3%,41/60)、网格状影(45.0%,27/60)、磨玻璃样(31.7%,19/60)、云絮状影(15.0%,9/60)、蜂窝状影(10.0%,6/60)等表现多见,可单独或同时出现;NILD组25.4%(15/59)的肺部HRCT也会出现少量条索影、斑片影、磨玻璃影等,但其病变部位、分布范围和病变程度均不满足ILD的影像学诊断标准,多属既往疾病的陈旧性改变。逐步Logistic回归分析结果显示,年龄、干咳、活动后气促、关节炎、GLOB、抗Jo-1抗体水平是PM/DM-ILD的影响因素(P<0.05)。ILD组患者重复住院率(χ^2=5.275,P=0.022)、肺部感染致重复住院率(P=0.010)高于NILD组。两组治疗效果比较,差异无统计学意义(χ^2=0.192,P=0.909)。结论年龄大,干咳、关节炎、活动后气促症状,血清抗Jo-1抗体阳性,GLOB水平升高是PM/DM-ILD发生的危险因素,对表现上述症状及血清学结果的高龄患者需密切检测其肺 Background Concurrent interstitial lung disease(ILD)in patients with polymyositis(PM)and dermatomyositis(DM)is a major cause of death with a fatality rate that exceeds 50%.However,there are currently few domestic studies on the clinical characteristics and related influencing factors of PM/DM combined with ILD(PM/DM-ILD) with different results,and there is still no valid evidence to confirm which factors are related to the occurrence of PM/DM-ILD.Objective To explore the clinical characteristics of PM/DM-ILD and its influencing factors.Methods A total of 119 patients with PM/DM who were treated in the Affiliated Hospital of North Sichuan Medical College from January 1,2014 to June 30,2018 were selected as subjects and divided into ILD group and non-interstitial lung disease(NILD)group.The general data,clinical symptoms,laboratory parameters,results of lung high-resolution CT(HRCT)and prognosis of the two groups were compared.Stepwise Logistic regression was used to analyze the influencing factors of PM/DM-ILD.Results The age,the first episode of arthritis,the first episode of respiratory symtom,mechanic’s hand,Reynolds phenomenon,dry cough,expectoration,post-exercise shortness of breath,fever,incidence of arthritis,erythrocyte sedimentation rate(ESR),globulin(GLOB) level,positive rate of anti-Jo-1 antibody of patients in ILD group were higher than those of patients in the NILD group,while the first episode of myasthenia,creatine kinase(CK),CK/glutamic-oxalacetic transaminase(AST),albumin(ALB) level of patients in ILD group were lower than those of patients in NILD group(P<0.05).Lung HRCT manifestations of 60 patients of the ILD group were mainly stripe shadow(68.3%,41/60),patchy shadow(68.3%,41/60),reticulate shadow(45.0%,27/60),ground glass opacity shadow(31.7%,19/60),cloud flocculent shadow(15.0%,9/60),and honeycomb shadow(10.0%,6/60),which could be seen alone or simultaneously.In NILD group,25.4%(15/59) of lung HRCT also showed a small amount of stripe shadow,patchy shadow and ground glass opacity shadow whi
作者 唐子猗 易婷 王聃 郑建雄 熊琴 张全波 青玉凤 TANG Ziyi;YI Ting;WANG Dan;ZHENG Jianxiong;XIONG Qin;ZHANG Quanbo;QING Yufeng(Department of Rheumatology and Immunology,the Affiliated Hospital of North Sichuan Medical College,Nanchong 637000, China;Department of Geriatrics,the Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,China;Precision Medicine Key Laboratory of Sichuan Province & Precision Medicine Center,West China Hospital,Sichuan University,Chengdu 610041,China)
出处 《中国全科医学》 CAS 北大核心 2019年第16期1960-1965,共6页 Chinese General Practice
基金 四川省属高校科研创新团队(14TD0021) 四川大学华西医院专职博士后研发基金资助项目(2018HXBH017)
关键词 多发性肌炎 皮肌炎 肺疾病 间质性 临床特征 影响因素分析 Polymyositis Dermatomyositis Lung disease,interstitial Clinical characteristics Root cause analysis
  • 相关文献

参考文献5

二级参考文献17

  • 1无.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-834. 被引量:608
  • 2Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis[J]. Eur Respir J, 2010,35(4) : 821-829. 被引量:1
  • 3Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials [J]. Lancet, 2011, 377 (9779): 1760-1769. 被引量:1
  • 4King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis [J]. N Engl J Med, 2014, 370 (22): 2083-2092. 被引量:1
  • 5Iwasawa T, Ogura T, Sakai F, et al. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis[J]. Eur J Radiol, 2014,83(1) :32-38. 被引量:1
  • 6Udwadia ZF, Mullerpattan JB, Balakrishnan C, et al. Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis[J]. Lung India, 2015,32 ( 1), 50-52. 被引量:1
  • 7Miura Y, Saito T, Fujita K, et al. Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease[J]. Sarcoidosis Vasc Diffuse Lung Dis,2014, 31(3) :235-238. 被引量:1
  • 8Nagai S, Hamada K, Shigematsu M, et al. Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis[J]. Intern Med, 2002,41(12): 1118-1123. 被引量:1
  • 9张德平,康健.结缔组织病相关性间质性肺炎与特发性间质性肺炎的鉴别[J].中华结核和呼吸杂志,2009,32(7):532-534. 被引量:10
  • 10俞咏梅,徐亮,武江,李志,李庆祝.高分辨率CT及积分在结缔组织病并发间质性肺炎及预后中的价值[J].中华风湿病学杂志,2009,13(12):812-815. 被引量:23

共引文献124

同被引文献79

引证文献9

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部